Kura Oncology, Inc.

General ticker "KURA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.3B (TTM average)

Kura Oncology, Inc. does not follow the US Stock Market performance with the rate: -12.2%.

Estimated limits based on current volatility of 1.9%: low 6.33$, high 6.57$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.41$, 12.19$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.96$, 8.38$]

Financial Metrics affecting the KURA estimates:

  • Negative: Non-GAAP EPS, $ of -2.03 <= 0.04
  • Positive: Operating cash flow per share per price, % of 15.47 > 12.73
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: 43.26 < Shareholder equity ratio, % of 54.41 <= 63.75
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: 0 < Interest expense per share, $ of 0.02
  • Positive: -3.20 < Investing cash flow per share, $ of -1.18

Similar symbols

Short-term KURA quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-025.566.577.58
Price $

Long-term KURA plot with estimates

5101520Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
KURAS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $53.88MM
Operating Expenses $139.87MM $165.80MM $247.08MM
Operating Income $-139.87MM $-165.80MM $-193.19MM
Non-Operating Income $4.03MM $13.17MM $21.23MM
Interest Expense $0.23MM $1.55MM $1.62MM
R&D Expense $92.81MM $115.23MM $169.97MM
Income(Loss) $-135.84MM $-152.63MM $-171.97MM
Taxes $0.00MM $0.00MM $2.02MM
Profit(Loss)* $-136.07MM $-152.63MM $-173.98MM
Stockholders Equity $420.28MM $397.27MM $413.64MM
Assets $456.31MM $448.94MM $760.16MM
Operating Cash Flow $-110.06MM $-124.82MM $134.32MM
Capital expenditure $0.63MM $0.17MM $0.47MM
Investing Cash Flow $32.63MM $15.56MM $-101.59MM
Financing Cash Flow $38.56MM $94.78MM $154.42MM
Earnings Per Share** $-2.03 $-2.08 $-2.02

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.